On April 25, FDA announced that it will regulate smokeless electronic cigarettes as tobacco products and not as drug-delivery devices, which are subject to more stringent regulation.  FDA, warned, however, that it could regulate electronic cigarettes as drugs or drug-delivery devices if the products are “marketed for therapeutic purposes,” such as a smoking cessation aid.

Although FDA said it will propose rule changes to treat e-cigarettes the same as cigarettes and other tobacco product, no timeline for the proposed rule changes has been given.

For questions and/or comments, please contact Bryan Haynes, at 804.697.1420 or by email.